N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide

C46H62N8O8 — CID 134212932

IUPACN-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
SMILESCC(C)CC(NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)C(C)(O)COn1nnc2ccccc21
InChIInChI=1S/C46H62N8O8/c1-31(2)26-37(42(56)46(5,60)30-62-54-40-19-13-12-18-35(40)51-52-54)48-45(59)39(28-34-16-10-7-11-17-34)50-44(58)38(27-32(3)4)49-43(57)36(21-20-33-14-8-6-9-15-33)47-41(55)29-53-22-24-61-25-23-53/h6-19,31-32,36-39,60H,20-30H2,1-5H3,(H,47,55)(H,48,59)(H,49,57)(H,50,58)/t36-,37-,38?,39-,46?/m0/s1
InChIKeyNTNBKSBDKHBDPF-MATSAALISA-N
MW855.05 g/mol
LogP2.42
Rot. Bonds23

About N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide

N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide (PubChem CID 134212932) has the molecular formula C46H62N8O8 and a molecular weight of 855.05 g/mol. Its IUPAC name is N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide.

Molecular Properties

Compound NameN-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
PubChem CID134212932
Molecular FormulaC46H62N8O8
Molecular Weight855.05 g/mol
Exact Mass854.47
IUPAC NameN-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
SMILESCC(C)CC(NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)C(C)(O)COn1nnc2ccccc21
InChIInChI=1S/C46H62N8O8/c1-31(2)26-37(42(56)46(5,60)30-62-54-40-19-13-12-18-35(40)51-52-54)48-45(59)39(28-34-16-10-7-11-17-34)50-44(58)38(27-32(3)4)49-43(57)36(21-20-33-14-8-6-9-15-33)47-41(55)29-53-22-24-61-25-23-53/h6-19,31-32,36-39,60H,20-30H2,1-5H3,(H,47,55)(H,48,59)(H,49,57)(H,50,58)/t36-,37-,38?,39-,46?/m0/s1
InChIKeyNTNBKSBDKHBDPF-MATSAALISA-N
XLogP2.42
TPSA206.11 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds23
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500855.05
LogP ≤ 52.42
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide?
The IUPAC name of N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide (CID 134212932) is N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide.
What is the SMILES notation for N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide?
The canonical SMILES for N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide is CC(C)CC(NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)C(C)(O)COn1nnc2ccccc21.
What is the InChIKey of N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide?
The InChIKey is NTNBKSBDKHBDPF-MATSAALISA-N. The full InChI is InChI=1S/C46H62N8O8/c1-31(2)26-37(42(56)46(5,60)30-62-54-40-19-13-12-18-35(40)51-52-54)48-45(59)39(28-34-16-10-7-11-17-34)50-44(58)38(27-32(3)4)49-43(57)36(21-20-33-14-8-6-9-15-33)47-41(55)29-53-22-24-61-25-23-53/h6-19,31-32,36-39,60H,20-30H2,1-5H3,(H,47,55)(H,48,59)(H,49,57)(H,50,58)/t36-,37-,38?,39-,46?/m0/s1.
What are the key properties of N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide?
N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide has a molecular weight of 855.05 g/mol, XLogP of 2.42, 23 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-[[(4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide is sourced from PubChem (CID 134212932), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).